NEUEHEALTH INC (NEUE) Stock Analyst Earnings Estimates
NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.412B 59.42% | 1.161B -51.87% | 937M -19.28% | 1.255B 33.94% | 1.329B 5.90% | |
| EBITDA YoY % growth | -424.4M -38.69% | -145M 65.83% | -78M 46.21% | 50.298M 164.48% | 64.267M 27.77% | |
| EBIT YoY % growth | -475M -39.09% | -169M 64.42% | -94M 44.38% | -54.366M 42.16% | -39.984M 26.45% | |
| Operating Margin | -19.69% | -14.56% | -10.03% | -4.33% | -3.01% | |
| EPS YoY % growth | -128.80 -11.32% | -6.86 94.67% | -19.76 -188.05% | -16.99 14.00% | -14.90 12.30% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -4.39 39.67% | -3.72 5.03% | -4.62 -348.60% |
| Revenue Q2Q % growth | 300.81M 33.11% | 307.35M 31.95% | 324.84M 39.63% |
| EBITDA Q2Q % growth | 11.74M 167.24% | 16.368M 427.36% | 13.041M 218.13% |
| EBIT Q2Q % growth | -14.484M 44.29% | -9.792M 42.40% | -16.422M 39.27% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.47 106.23% | -4.26 | 4.73 | 111.02% |
| Q4 2024 Q2Q % growth | -1.03 -105.14% | -4.07 | 3.04 | 74.72% |
| Q3 2024 Q2Q % growth | -3.92 54.04% | -3.16 | -0.76 | -23.97% |
| Q2 2024 Q2Q % growth | -7.27 -82.66% | -3.33 | -3.94 | -118.63% |
| Q1 2024 Q2Q % growth | -7.54 47.64% | -5.41 | -2.13 | -39.47% |
| Q4 2023 Q2Q % growth | 20.05 173.71% | -4.24 | 24.29 | 572.52% |
| Q3 2023 Q2Q % growth | -8.53 78.68% | -4.45 | -4.08 | -91.81% |
| Q2 2023 Q2Q % growth | -3.98 88.94% | -5.55 | 1.57 | 28.34% |
| Q1 2023 Q2Q % growth | -14.40 43.75% | -7.75 | -6.65 | -85.76% |
| Q4 2022 Q2Q % growth | -27.20 -2,008.53% | -41.62 | 14.42 | 34.64% |
| Q3 2022 Q2Q % growth | -40.00 -8,233.33% | -29.70 | -10.30 | -34.67% |
| Q2 2022 Q2Q % growth | -36.00 -12,757.14% | -26.30 | -9.70 | -36.87% |
| Q1 2022 Q2Q % growth | -25.60 | -19.73 | -5.87 | -29.76% |
| Q4 2021 Q2Q % growth | -1.29 | -0.46 | -0.83 | -181.40% |
| Q3 2021 Q2Q % growth | -0.48 | -0.15 | -0.33 | -226.05% |
| Q2 2021 Q2Q % growth | -0.28 | -0.16 | -0.12 | -71.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 215.787M -11.96% | 322.32M | -106.533M | -33.05% |
| Q4 2024 Q2Q % growth | 232.638M -20.57% | 256.97M | -24.332M | -9.47% |
| Q3 2024 Q2Q % growth | 232.933M -13.54% | 239.58M | -6.647M | -2.77% |
| Q2 2024 Q2Q % growth | 225.991M -69.77% | 257.53M | -31.539M | -12.25% |
| Q1 2024 Q2Q % growth | 245.095M -67.59% | 253.48M | -8.385M | -3.31% |
| Q4 2023 Q2Q % growth | 292.871M -84.49% | 289.11M | 3.761M | 1.30% |
| Q3 2023 Q2Q % growth | 269.399M 39.30% | 290.1M | -20.701M | -7.14% |
| Q2 2023 Q2Q % growth | 747.68M 400.79% | 767.09M | -19.41M | -2.53% |
| Q1 2023 Q2Q % growth | 756.341M 318.33% | 787.96M | -31.619M | -4.01% |
| Q4 2022 Q2Q % growth | 1.889B 221.53% | 1.764B | 124.6M | 7.06% |
| Q3 2022 Q2Q % growth | 193.4M -82.07% | 1.802B | -1.609B | -89.27% |
| Q2 2022 Q2Q % growth | 149.3M -86.60% | 1.849B | -1.7B | -91.93% |
| Q1 2022 Q2Q % growth | 180.8M -79.33% | 1.78B | -1.599B | -89.84% |
| Q4 2021 Q2Q % growth | -1.554B -367.09% | 1.102B | -2.656B | -241.02% |
| Q3 2021 Q2Q % growth | 1.079B 206.36% | 1.106B | -27.3M | -2.47% |
| Q2 2021 Q2Q % growth | 1.114B 275.14% | 1.059B | 54.8M | 5.17% |
| Q1 2021 Q2Q % growth | 874.6M 340.38% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |